Precuneus degeneration and isolated apathy in patients with Parkinson's disease.

Shin JH, Shin SA, Lee JY, Nam H, Lim JS, Kim YK.

Neurosci Lett. 2017 Jun 1;653:250-257. doi: 10.1016/j.neulet.2017.05.061. [Epub ahead of print]

Algorithm for Turning Detection and Analysis Validated under Home-Like Conditions in Patients with Parkinson's Disease and Older Adults using a 6 Degree-of-Freedom Inertial Measurement Unit at the Lower Back.

Pham MH, Elshehabi M, Haertner L, Heger T, Hobert MA, Faber GS, Salkovic D, Ferreira JJ, Berg D, Sanchez-Ferro Á, van Dieën JH, Maetzler W.

Front Neurol. 2017 Apr 10;8:135. doi: 10.3389/fneur.2017.00135. eCollection 2017.

Association between SNCA rs2736990 polymorphism and Parkinson's disease: a meta- analysis.

Fang J, Hou B, Liu H, Zhang X, Wang J, Zhou C, Xie A.

Neurosci Lett. 2017 Aug 24. pii: S0304-3940(17)30698-5. doi: 10.1016/j.neulet.2017.08.051. [Epub ahead of print]

Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease.

Elgueta D, Aymerich MS, Contreras F, Montoya A, Celorrio M, Rojo-Bustamante E, Riquelme E, González H, Vásquez M, Franco R, Pacheco R.

Neuropharmacology. 2017 Feb;113(Pt A):110-123. doi: 10.1016/j.neuropharm.2016.09.028.

Adenosine-sensitive Wolff-Parkinson-White: Longer time across the atrioventricular groove.

Beach C, Follansbee CW, Beerman L, Mazzocco S, Wang L, Arora G.

Pacing Clin Electrophysiol. 2017 Dec 9. doi: 10.1111/pace.13257. [Epub ahead of print]

Reproductive factors and risk of Parkinson's Disease in women: a meta-analysis of observational studies.

Lv M, Zhang Y, Chen GC, Li G, Rui Y, Qin L, Wan Z.

Behav Brain Res. 2017 Jul 22. pii: S0166-4328(17)30930-0. doi: 10.1016/j.bbr.2017.07.025. [Epub ahead of print] Review.

The relevance of gender in Parkinson's disease: a review.

Picillo M, Nicoletti A, Fetoni V, Garavaglia B, Barone P, Pellecchia MT.

J Neurol. 2017 Jan 4. doi: 10.1007/s00415-016-8384-9. [Epub ahead of print] Review.

Present and future selves in Parkinson's disease.

Ernst A, Allen J, Dubourg L, Souchay C.

Neurocase. 2017 Aug 13:1-10. doi: 10.1080/13554794.2017.1365909. [Epub ahead of print]

Efficacy of rasagiline for the treatment of Parkinson's disease: an updated meta-analysis.

Chang Y, Wang LB, Li D, Lei K, Liu SY.

Ann Med. 2017 Mar 15:1-14. doi: 10.1080/07853890.2017.1293285. [Epub ahead of print]

Effects of dopamine on reinforcement learning and consolidation in Parkinson's disease.

Grogan JP, Tsivos D, Smith L, Knight BE, Bogacz R, Whone A, Coulthard EJ.

Elife. 2017 Jul 10;6. pii: e26801. doi: 10.7554/eLife.26801.

Parkinson disease repurposing promise.

Mullard A.

Nat Rev Drug Discov. 2017 Sep 29;16(10):669. doi: 10.1038/nrd.2017.198. No abstract available.

Striatal and Hippocampal Atrophy in Idiopathic Parkinson's Disease Patients without Dementia: A Morphometric Analysis.

Tanner JJ, McFarland NR, Price CC.

Front Neurol. 2017 Apr 13;8:139. doi: 10.3389/fneur.2017.00139. eCollection 2017.

Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.

Müller T.

Expert Opin Pharmacother. 2017 Aug 29. doi: 10.1080/14656566.2017.1373089. [Epub ahead of print]

Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients.

Gao C, Chen YM, Sun Q, He YC, Huang P, Wang T, Li DH, Liang L, Liu J, Xiao Q, Chen SD.

Neurobiol Aging. 2017 Jan;49:218.e9-218.e11. doi: 10.1016/j.neurobiolaging.2016.10.001.

Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's disease.

Wang CT, Mao CJ, Zhang XQ, Zhang CY, Lv DJ, Yang YP, Xia KL, Liu JY, Wang F, Hu LF, Xu GY, Liu CF.

Mol Pain. 2017 Jan;13:1744806917691525. doi: 10.1177/1744806917691525.